✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals

Aristo Bio-Tech and Lifescience Ltd.

ARISTO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹83 Cr.
P/E
20.53

Aristo Bio-Tech and Lifescience Ltd.

  • Aristo Bio-Tech&Lis
  • Crop Life Science
  • Ambey Laboratories

FAQs on Aristo Bio-Tech and Lifescience Ltd. Shareprice

Aristo Bio-Tech&Lis has given better returns compared to its competitors.
Aristo Bio-Tech&Lis has grown at ~-15.08% over the last 1yrs while peers have grown at a median rate of -18.0%

Aristo Bio-Tech&Lis is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Aristo Bio-Tech&Lis is 20.53, while 3 year average PE is 18.01.
Also latest EV/EBITDA of Aristo Bio-Tech&Lis is 6.04 while 3yr average is 7.68.

View FAQ's On Business

Growth Table

  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Balance Sheet

  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Cash Flow

  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Quarterly Results

  • Aristo Bio-Tech and Lifescience Ltd.
  • Crop Life Science
  • Ambey Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Aristo Bio-Tech and Lifescience Ltd. Financials

Balance sheet of Aristo Bio-Tech&Lis is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Aristo Bio-Tech&Lis is increasing.
Latest net debt of Aristo Bio-Tech&Lis is ₹32.6 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹19.63 Crs.

The profit is oscillating.
The profit of Aristo Bio-Tech&Lis is ₹3.68 Crs for TTM, ₹4.06 Crs for Mar 2025 and ₹3.9 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aristo Bio-Tech&Lis latest dividend payout ratio is 8.38% and 3yr average dividend payout ratio is 6.72%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech